1887

Abstract

SUMMARY

Fresh human sera neutralize Friend leukaemia virus (FLV). The activity is abolished by heating (56 °C for 30 min), hydrazine and EDTA treatment, suggesting the involvement of complement. Human sera also contain antibody which specifically reacts with FLV. Following incubation with human whole serum, IgG and F(ab′) fragments, FLV acquire the ability to bind anti-human Ig sera, as shown in neutralization and radioimmunoprecipitation assays. The same is true for FLV-infected cells but not for uninfected control cells, as assessed by immunofluorescence. The binding of antibody to FLV-infected cells is prevented by pre-treating the cells with antisera to FLV and FLV-gp71, and is competed by FLV, FLV-gp71 and, to a lesser extent, by FLV-p12 and p30.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-46-2-311
1980-02-01
2021-10-16
Loading full text...

Full text loading...

/deliver/fulltext/jgv/46/2/JV0460020311.html?itemId=/content/journal/jgv/10.1099/0022-1317-46-2-311&mimeType=html&fmt=ahah

References

  1. Aaronson S. A., Stephenson J. R. 1974; Widespread natural occurrence of high titered neutralizing antibodies to a specific class of endogenous murine type‒C virus. Proceedings of the National Academy of Sciences of the United States of America 71:1957–1961
    [Google Scholar]
  2. Aoki T., Liu M., Walling M. J., Bushar G. S., Brandchaft P. B., Kawakami T. G. 1976a; Specificity of naturally occurring antibody in normal gibbon serum. Science 191:1180–1183
    [Google Scholar]
  3. Aoki T., Walling M. J., Bushar G. S., Liu M., Hsu K. C. 1976b; Natural antibodies in sera from healthy humans to antigens on surfaces of type–C RNA viruses and cells from primates. Proceedings of the National Academy of Sciences of the United States of America 73:2491–2495
    [Google Scholar]
  4. Bartholomew R. M., Esser A. F., Muller–Eberhard H. J. 1978; Lysis of oncornaviruses by human serum. Isolation of the viral complement (Cl) receptor and identification as P15E. Journal of Experimental Medicine 147:844–853
    [Google Scholar]
  5. Bassin R. N., Tuttle N., Fischinger P. J. 1971; Rapid cell culture assay technique for murine leukemia viruses. Nature, London 229:564–566
    [Google Scholar]
  6. Bauer H. 1974; Virion and tumor cell antigens of C–type RNA tumour viruses. Advances in Cancer Research 20:275–341
    [Google Scholar]
  7. Bendinelli M., Nardini L., Campa M. 1974; Neutralization of Friend leukemia virus by sera of unimmunized animals. Journal of General Virology 22:207–214
    [Google Scholar]
  8. Charman H. P., Kim N., White M., Gilden R. V. 1974; Failure to detect in human sera, antibodies crossreactive with group specific antigens of murine leukemia virus. Journal of the National Cancer Institute 52:1409–1413
    [Google Scholar]
  9. Cloyd M. W., Bolognesi D. P., Bigner D. D. 1977; Immunofluorescent analysis of expression of the RNA tumour virus major glycoprotein, gp71, on the surface of normal murine cells. Cancer Research 37:931–938
    [Google Scholar]
  10. Cooper N. R., Jensen F. C., Welsh R. M. Jun, OLDsy–ONE M. B. A. 1976; Lysis of RNA tumor viruses by human serum: direct antibody–independent triggering of the classical complement pathway. Journal of Experimental Medicine 144:970–984
    [Google Scholar]
  11. Fieldsteel A. H. 1974; Nonspecific antiviral substances in human milk active against arbovirus and murine leukemia virus. Cancer Research 34:712–715
    [Google Scholar]
  12. Fink M. A., Malgren R. A., Rauscher F. J., Orr H. C., Karon M. 1964; Application of immunofluorescence to the study of human leukemia. Journal of the National Cancer Institute 33:581–588
    [Google Scholar]
  13. Friend C., Scher W., Tsuei D., Haddad J., Holland J. G., Szrajer N., Haubenstock H. 1979; Perspectives on Friend leukemia virus: pathogenesis in vivo and studies on the control of erythrodifferentiation in vitro. In Oji International Seminar on Oncogenic Viruses and Host Cell Genes 1977 Yamanaka Lake pp 279–301 Edited by Ikawa Y., Odaka T. New York: Academic Press;
    [Google Scholar]
  14. Golde D. W., Cline M. S. 1973; Growth of human bone marrow in liquid culture. Blood 41:45–52
    [Google Scholar]
  15. Green R. W., Bolognesi D. P., Schafer W., Pister L., Hunsmann G., De Noronha F. 1973; Polypeptides of mammalian oncornaviruses. I. Isolation and serological analysis of polypeptides from murine and feline C–type viruses. Virology 45:565–579
    [Google Scholar]
  16. Hehlmann R. 1976; RNA tumour viruses and human cancer. Current Topics in Microbiology and Immunology 73:141–215
    [Google Scholar]
  17. Hersh E. M., Hanna M. G., Gutterman J. U., Mavligit G., Yurconic M., Gschwind C. R. 1974; Human immune response to active immunization with Rauscher leukemia virus. II. Humoral immunity. Journal of the National Cancer Institute 53:327–333
    [Google Scholar]
  18. Hirsch M. S., Kelly A. P., Chapin D. S., Fuller T. C., Black P. H., Kurth R. 1978; Immunity to antigens associated with primate C–type oncornaviruses in pregnant women. Science 199:1337–1340
    [Google Scholar]
  19. Holder W. O., Geer G. W., Bolognesi D. B., Wells S. A. Jun 1976; Detection of the major glycoproteins of Friend leukemia virus (gp71) and the murine mammary tumor virus (gp 52) on the surface of mouse cells. Cancer Research 36:3217–3224
    [Google Scholar]
  20. Jacquemin P. C., Saxinger C., Gallo R. C. 1978; Surface antibodies of human myelogenous leukaemia leukocytes reactive with specific type–C viral reverse transcriptases. Nature, London 276:230–236
    [Google Scholar]
  21. Kim B. S. 1975; Presence of antibody to a primate RNA virus in human plasma. Nature, London 257:614–616
    [Google Scholar]
  22. Krakower J. M., Aaronson S. A. 1978; Seroepidemiological assessment of feline leukaemia virus infection risk for man. Nature, London 273:463–464
    [Google Scholar]
  23. Kurth R., Mikschy U. 1978; Human antibodies reactive with purified envelope antigens of primate type C tumor viruses. Proceedings of the National Academy of Sciences of the United States of America 75:5692–5696
    [Google Scholar]
  24. Kurth R., Teich N. M., Weiss R., Oliver R. T. D. 1977; Natural human antibodies reactive with primate type–C viral antigens. Proceedings of the National Academy of Sciences of the United States of America 74:1237–1241
    [Google Scholar]
  25. Ihle J. N., Hanna M. G. Jun, Robertson L. E., Kenney F. T. 1974; Autogenous immunity to endogenous RNA tumor virus. Identification of antibody reactivity to select viral antigens. Journal of Experimental Medicine 139:1568–1581
    [Google Scholar]
  26. Lee J. C., Ihle J. N. 1975; Autogenous immunity to endogenous RNA tumor virus: reactivity of natural immune sera to antigenic determinants of several biologically distinct murine leukemia viruses. Journal of the National Cancer Institute 55:831–838
    [Google Scholar]
  27. Lewis R. M., Tannenberg W., Smith C., Schwartz R. S. 1974; C–type viruses in systemic lupus erythematosus. Nature, London 252:78–79
    [Google Scholar]
  28. Louie S., Curtis J. E., McCulloch E. A. 1976; Antibodies in human sera to oncornavirus–like proteins from normal or leukemic marrow cell cultures. Journal of Experimental Medicine 144:1243–1253
    [Google Scholar]
  29. Mellors R. C., Mellors J. W. 1978; Type–C RNA virus specific antibody in human lupus erythematosus demonstrated by enzymoimmunoassay. Proceedings of the National Academy of Sciences of the United States of America 75:2463–2467
    [Google Scholar]
  30. Moennig V., Hunsmann G., Schafer W. 1973; Partielle reinigung und biologisch–serologische charak– terisierung Kohnenhydrat kalkiger komponenten aus prdparater von Friend–leukamie virus. Zeitschrift fur Naturforschung 284:785–788
    [Google Scholar]
  31. Nisonoff A., Wissler F. C., Iipman L. N., Woernley D. L. 1960; Separation of univalent fragments from the bivalent rabbit antibody molecule by reduction of disulfide bonds. Archives of Biochemistry 89:230–244
    [Google Scholar]
  32. Olsen R. G., Yohn D. S. 1974; Antibodies in human sera to the mammalian oncornaviruses interspecies antigen. Proceedings of the American Association of Cancer Research 14:61–67
    [Google Scholar]
  33. Prochownik E. V., Kirsten W. H. 1976; Inhibition of reverse transcriptases of primate type–C viruses by 7S immunoglobulin from patients with leukaemia. Nature, London 260:64–67
    [Google Scholar]
  34. Revoltella R., Pediconi M., Bertolini L., Bosman C. 1975; In vitro immune response by murine bone marrow cells stimulated against soluble immune complexes. Cellular Immunology 20:117–132
    [Google Scholar]
  35. Revoltella R., Bertolini L., Friend C. 1979; In vitro erythroleukemic transformation of mouse bone marrow cells by Friend leukemia virus. Proceedings of the National Academy of Sciences of the United States of America 76:1464–1468
    [Google Scholar]
  36. Rowe W. P., Pugh W. E., Hartley J. W. 1970; Plaque assay techniques for murine leukemia viruses. Virology 42:1136–1139
    [Google Scholar]
  37. Schafer W., Lange J., Fischinger P. J., Frank H., Bolognesi D. P., Green R. W., Huper G. 1975; Polypeptides of mammalian oncornaviruses. II. Characterization of a mouse leukemia virus polypeptide (P15) bearing interspecies reactivity. Virology 63:48–59
    [Google Scholar]
  38. Sherwin S. A., Benveniste R. E., Todaro G. J. 1978; Complement–mediated lysis of type–C virus: effect of primate and human sera on various retroviruses. International Journal of Cancer 21:6–11
    [Google Scholar]
  39. Simkovic D., Chorvath B., Hlubinova K. 1977; Presence of complement–fixing antibodies against antigens of Gross virus–induced rat lymphoma and normal rat thymus in sera of patients with some forms of malignancies. Neoplasma 24:357–363
    [Google Scholar]
  40. Snyder H. W., Fox M. 1978; Characterization of foetal calf serum–derived molecule reactive with human natural antibodies: its occurrence in tissue culture–grown type–C RNA viruses. Journal of Immunology 120:646–651
    [Google Scholar]
  41. Snyder H. W., Pincus T., Fleissner E. 1976; Specificities of human immunoglobulins reactive with antigens in preparations of several mammalian type–C viruses. Virology 75:60–73
    [Google Scholar]
  42. Stephenson J. R., Aaronson S. A. 1976; Search for antigens and antibodies cross–reactive with type–C viruses of the woolly monkey and gibbon ape in animal models and in humans. Proceedings of the National Academy of Sciences of the United States of America 73:1725–1729
    [Google Scholar]
  43. Strand M., Lilly F., August J. T. 1974; Host control of endogenous murine leukemia virus gene expression : concentrations of viral proteins in high and low leukemia mouse strains. Proceedings of the National Academy of Sciences of the United States of America 70:3682–3686
    [Google Scholar]
  44. Thiry L., Sprecher–Goldberger S., Bossens M., Cogniaux–Le Clerc J., Vereestraten P. 1978; Neutralization of Mason–Pfizer virus by sera from patients treated for renal disease. Journal of General Virology 41:587–597
    [Google Scholar]
  45. Witkin S. S., Higgins P. J., Bendich A. 1978; Inhibition of viral reverse transcriptase and human sperm DNA polymerase by anti–sperm antibodies. Clinical and Experimental Immunology 33:244–251
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-46-2-311
Loading
/content/journal/jgv/10.1099/0022-1317-46-2-311
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error